

|
RESEARCH AND PUBLICATIONS |
|
|
|
 |
Prof Justus Apffelstaedt and Associates is an active participating centre in multicentre clinical trials that have defined breast cancer treatment in the past and will define breast cancer treatment in the future.
Members of the team of Prof Justus Apffelstaedt and Associates participated, amongst others, in the ATAC, BIG-I-98, FASLODEX, LETROZOLE and SABRE trials.
| LINKS TO PUBLICATIONS |
Apffelstaedt JP, Steenkamp V, Baatjes K.
S Afr Med J. 2008 Dec;98(12):950-3.PMID: 19374072 [PubMed - indexed for MEDLINE
Performance data of screening mammography at a dedicated breast health centre |
|
Mohamad HB, Apffelstaedt JP.

Counseling for male BRCA mutation carriers - a review.
Breast. 2008 Oct;17(5):441-50. Epub 2008 Jul 26.
PMID: 18657973 [PubMed - in process] |
|
|
Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJ.

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer. 2003 Oct 15;98(8):1735-44.
PMID: 14534891 [PubMed - indexed for MEDLINE] |
|
Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jaenicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Chaudri-Ross H, Lang R, Wyld P, Bhatnagar A.

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.
J Clin Oncol. 2003 Jun 1;21(11):2101-9.
PMID: 12775735 [PubMed - indexed for MEDLINE] |
|
|
Apffelstaedt J.

|
Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y.

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Cancer J. 2001 Sep-Oct;7(5):377-87.
PMID: 11693896 [PubMed - indexed for MEDLINE] |
Mouridsen H, Gershanovich M, Sun Y, Pérez-Carrión R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Jänicke F, Pluzanska A, Dank M, Becquart D, Bapsy PP, Salminen E, Snyder R, Lassus M, Verbeek JA, Staffler B, Chaudri-Ross HA, Dugan M.

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.
J Clin Oncol. 2001 May 15;19(10):2596-606. Erratum in: J Clin Oncol 2001 Jul 1;19(13):3302.
PMID: 11352951 [PubMed - indexed for MEDLINE] |
|
|
Apffelstaedt JP, Driscoll DL, Spellman JE, Velez AF, Gibbs JF, Karakousis CP.

Complications and outcome of external hemipelvectomy in the management of pelvic tumors.
Ann Surg Oncol. 1996 May;3(3):304-9.
PMID: 8726187 [PubMed - indexed for MEDLINE] |
Apffelstaedt JP, Zhang PJ, Driscoll DL, Karakousis CP.

Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors.
Surg Oncol. 1995 Aug;4(4):217-22.
PMID: 8528484 [PubMed - indexed for MEDLINE] |
|
|
Apffelstaedt JP, Müller R.

Results of mandatory exploration for penetrating neck trauma.
World J Surg. 1994 Nov-Dec;18(6):917-9; discussion 920.
PMID: 7846919 [PubMed - indexed for MEDLINE] |
|
|
|
| |
|
|
|
|
|
|